Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Ixazomib

EU orphan designation number: EU/3/12/1060   
Active ingredient: Ixazomib
Indication: Treatment of systemic light chain amyloidosis
Sponsor: Takeda Development Centre Europe Ltd
61 Aldwych, London WC2B 4AE, United Kingdom

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
12/11/2012 Centralised Orphan - Designation EMA/OD/110/12 (2012)8193 of 08/11/2012
12/11/2013 Centralised Orphan - Change of address